Xin Liu

Title: Innovations of Inventor Xin Liu

Introduction

Xin Liu is a notable inventor based in Chongqing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the prevention and treatment of sepsis and autoimmune diseases. With a total of 2 patents, his work focuses on utilizing traditional Chinese medicine to develop effective drug formulations.

Latest Patents

One of Xin Liu's latest patents is titled "Use of Kukoamine A and Kukoamine B." This patent discloses the use of Kukoamine A and Kukoamine B in the preparation of drugs aimed at preventing and treating sepsis and autoimmune diseases. The invention specifically targets bacterial endotoxin/lipopolysaccharide (LPS) and unmethylated DNA (CpG DNA), which are major pathogen-associated molecular patterns in these conditions. By isolating lead compounds from traditional Chinese medicine, this approach addresses the uncertainties surrounding the pharmacological material basis and drug targets of herbal extracts. This innovation aims to develop safe, effective, and quality-controllable drugs to fill the current gap in clinical treatment options.

Another significant patent is "Salts of Kukoamine B, Preparation Method and Use Thereof." This patent outlines the preparation method and pharmaceutical applications of salts of Kukoamine B for preventing and treating sepsis. Experimental results indicate that these salts effectively antagonize key factors that induce sepsis. Given the current lack of effective treatment measures in clinical practice, the medicinal formulations comprising salts of Kukoamine B offer a new approach to combat this serious condition.

Career Highlights

Xin Liu has worked with prominent organizations, including Tianjin Chase Sun Pharmaceutical Co., Ltd and The First Affiliated Hospital, Third Military Medical University. His experience in these institutions has contributed to his expertise in pharmaceutical research and development.

Collaborations

Xin Liu has collaborated with notable colleagues, including Jiang Zheng and Xinchuan Zheng, who have supported his innovative research endeavors.

Conclusion

Xin Liu's contributions to the field of pharmaceuticals, particularly through his patents on Kukoamine A and B, showcase his commitment to addressing critical health challenges. His work exemplifies the potential of traditional medicine in modern drug development, paving the way for new therapeutic options.